are ranitidine tablets being recalled?
478373
The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day or 0.32 parts per million for ranitidine).
449275
November 15, 2019 -- Golden State Medical Supply, Incorporated (GSMS, Inc) based upon a manufacturer's recall by Novitium Pharma LLC (Novitium), is voluntarily instituting a recall of all quantities and lots, within expiry, of Ranitidine HCl 150mg and 300mg Capsules to the consumer level because of potential presence ...
1330719
Update [7/27/2018] On July 13th, FDA announced a recall of certain batches of valsartan tablets because of an impurity, a chemical known as N-nitrosodimethylamine (NDMA). Valsartan is a medication commonly used to treat high blood pressure and heart failure.
409488
Lannett Ranitidine Recall On October 28, 2019 the FDA announced that Lannett Company, Inc. recalled all lots of its prescription ranitidine syrup. The recall includes Lannett's ranitidine oral solution prescribed in 15mg/mL doses due to the confirmed presence of NDMA.
126632
Clinicians should be aware that not all lots of valsartan, irbesartan and losartan products are being recalled, and other ARBs, including candesartan, eprosartan, olmesartan and telmisartan, have not been recalled.
459882
Reddy's Laboratories, the manufacturer of Kroger, Walgreen and CVS branded ranitidine products has issued a voluntary recall. Products dated for expiration between September 2019 and June 2021 are affected. These medications are over the counter and are used to treat heartburn.
886556
These medications contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day or 0.32 parts per million for ranitidine).
946065
WEDNESDAY, April 1, 2020 (HealthDay News) -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable cancer-causing chemical, the U.S. Food and Drug Administration said Wednesday.
195821
Appco Pharma LLC is voluntarily recalling prescription ranitidine hydrochloride capsules. Northwind Pharmaceuticals is voluntarily recalling prescription ranitidine tablets (150 mg and 300 mg), manufactured by Glenmark Pharmaceutical Inc.
687007
The Walgreens versions of recalled products are sold under the store brand name Wal-Zan. The Walmart and Rite Aid labeled versions are described as ranitidine tablets.
892739
The medicines are being recalled because they may contain unacceptable levels of N-nitrosodimethylamine (NDMA). FDA has advised companies to recall their ranitidine if testing shows levels of NDMA above the acceptable daily intake (96 nanograms per day).
1200142
Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets.
1199735
Products Affected by the Medicine Recall Drugs affected by the recall include: Exforge (amlodipine and valsartan) Exforge HCT (w/ hydrochlorothiazide) Diovan (valsartan)
982818
Officials with Alembic Pharmaceuticals, Inc. have issued a statement to patients, doctors, and pharmacists that Alembic's Valsartan containing products (Valsartan, Valsartan & Hydrochlorothiazide, Amlodipine & Valsartan) are not subject to the recent FDA recall.
545381
As a precautionary measure, Perrigo Company plc announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes). ... On October 8, 2019, Perrigo halted shipments of the product based upon preliminary results.
620349
Hypertension Drug Recalled. Lupin Pharmaceuticals Inc. is recalling more than 11,000 bottles of 20-mg lisinopril tablets after a customer reported finding 10-mg tablets in two sealed 20-mg tablet bottles. The recall was included in the April 29, 2020, US Food and Drug Administration (FDA) Enforcement Report.
61117
Teva Pharmaceuticals has issued a voluntary recall of its amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets, both used to treat high blood pressure, according to the FDA. The FDA announced the recall on its website Tuesday.